Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction

Authors

DOI:

https://doi.org/10.14739/2310-1210.2024.1.292909

Keywords:

chronic heart failure, ejection fraction, diastolic index

Abstract

Chronic heart failure (CHF) remains the leading cardiovascular disease worldwide. The prevalence of CHF with preserved ejection fraction (HFpEF) among other CHF phenotypes continues to rise. Despite a large number of studies focused on diagnosing this CHF phenotype, information on additional parameters for the verification of this disease phenotype are accumulating, and their prognostic values remain to be fully addressed. One such echocardiographic marker is the diastolic index that has proven its prognostic value in diagnosing HFpEF in the Japanese population. However, questions have been raised over the possibility of applying this parameter in the European population.

Aim. To prove the diagnostic and prognostic value of the diastolic index as an additional criterion for the HFpEF phenotyping in the European population.

Materials and methods. The study enrolled 88 patients (men – 46.6 % (n = 41); women – 53.4 % (n = 47)) with CHF of ischemic origin, stage II A–B, NYHA class II–IV. The patients were divided into two groups depending on heart rhythm disorder – 67 % (n = 59) with sinus rhythm and 33 % (n = 29) with atrial fibrillation (AF). Groups of patients were comparable in age (p = 0.483), height (p = 0.345), weight (p = 0.317), body surface area (p = 0.153). Doppler echocardiography was routinely performed on an Esaote MyLab Eight device (Italy). Blood pressure was measured with an automatic tonometer before each echocardiographic examination. The diastolic index was calculated according to the formula: Ed/Ea = (E/e’)/(0.9 × systolic blood pressure).

Results. The median follow-up of HFpEF was 1,200 days. During the observation period, 11 endpoints were registered, which amounted to 12.5 %. Analysis of the end point incidence rate depending on the presence of rhythm disturbances has not revealed a significant difference between the studied groups of patients: 13.56 % (8/51) in patients with sinus rhythm vs. 10.34 % (3/26) in patients with AF; log-rank test (p = 0.90060). No significant difference in end points has been found depending on sex between the studied groups: 9.3 % (4/43) in women vs. 20.6 % (7/34) in men; log-rank test (p = 0.65064). An increase in the diastolic index Ed/Ea over 0.0769 was associated with a 1.9-fold increase in the relative risk of adverse cardiovascular events in CHF patients with sinus rhythm (p = 0.0054) in contrast to CHF patients with AF. At the same time, an increase in the Ed/Ea parameter was not associated with an increase in the relative risk of adverse cardiovascular events in CHF patients with AF (p = 0.3466).

Conclusions. The index of diastolic elasticity Ed/Ea has demonstrated its prognostic value in the European population of elderly (over 70 years old) patients with HFpEF. An increase in the diastolic index over 0.0769 units was associated with a significant increase in the relative risk of adverse cardiovascular events by 1.9 times in HF patients with sinus rhythm. The diastolic index Ed/Ea has not confirmed its prognostic value in CHF patients with AF.

Author Biographies

V. V. Syvolap, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, DSc, Professor of the Department of Propaedeutic of Internal Medicine, Radiation Diagnostic and Radiation Therapy

V. A. Lysenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, Assistant of the Department of Propaedeutic of Internal Medicine, Radiation Diagnostic and Radiation Therapy

References

Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272-87. doi: https://doi.org/10.1093/cvr/cvac013

Kosiborod MN, Verma S, Borlaug BA, Butler J, Davies MJ, Jensen TJ, et al. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial. Circulation. 2023 Nov 12. doi: https://doi.org/10.1161/CIRCULATIONAHA.123.067505

Kolesnyk MY, Maistrovych YY. [Current diagnostic algorithms for chronic heart failure with preserved left ventricular ejection fraction]. Zaporozhye medical journal. 2023;25(1):72-80. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2023.1.270044

Obokata M, Reddy YN, Borlaug BA. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):245-57. doi: https://doi.org/10.1016/j.jcmg.2018.12.034

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. doi: https://doi.org/10.1016/j.echo.2014.10.003

Lysenko VA, Potapenko MS, Syvolap VV. [Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction]. Current issues in pharmacy and medicine: science and practice, 2021;14(1):93-102. Ukrainian. doi: https://doi.org/10.14739/2409-2932.2021.1.226853

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi: https://doi.org/10.1093/eurheartj/ehab368

Kosmala W, Rojek A, Przewlocka-Kosmala M, Mysiak A, Karolko B, Marwick TH. Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2016;67(6):659-70. doi: https://doi.org/10.1016/j.jacc.2015.10.096

Basu S, Yu H, Murrow JR, Hallow KM. Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling. PLoS Comput Biol. 2023;19(11):e1011598. doi: https://doi.org/10.1371/journal.pcbi.1011598

Hoshida S. Due Diligence of a Diastolic Index as a Prognostic Factor in Heart Failure with Preserved Ejection Fraction. J Clin Med. 2023;12(20):6692. doi: https://doi.org/10.3390/jcm12206692

Hoshida S, Shinoda Y, Tachibana K, Minamisaka T, Yamada T, Yasumura Y, et al. Impact of Afterload-Integrated Diastolic Indexon Prognosis in Elderly Patients with Heart Failure with Preserved Ejection Fraction with and without Atrial Fibrillation. J Atr Fibrillation. 2021;13(5):2469. doi: https://doi.org/10.4022/jafib.2469

Lysenko VА, Syvolap VV. [The impact of chronic heart failure on heart remodeling in patients with atrial fibrillation]. Zaporozhye medical journal. 2021;23(4):462-8. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2021.4.229002

Horodinschi RN, Diaconu CC. Comorbidities Associated with One-Year Mortality in Patients with Atrial Fibrillation and Heart Failure. Healthcare (Basel). 2021;9(7):830. doi: https://doi.org/10.3390/healthcare9070830

Fauchier L, Villejoubert O, Clementy N, Bernard A, Pierre B, Angoulvant D, et al. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. Am J Med. 2016;129(12):1278-87. doi: https://doi.org/10.1016/j.amjmed.2016.06.045

Suna S, Hikoso S, Yamada T, Uematsu M, Yasumura Y, Nakagawa A, et al. Study protocol for the PURSUIT-HFpEF study: a Prospective, Multicenter, Observational Study of Patients with Heart Failure with Preserved Ejection Fraction. BMJ Open. 2020;10(10):e038294. doi: https://doi.org/10.1136/bmjopen-2020-038294

Voronkov LH, Amosova KM, Dziak HV, Zharinov OY, Kovalenko VM, Korkushko OV, et al. [Guidelines of the Ukrainian Association of Cardiology for the Diagnosis and Treatment of Chronic Heart Failure (2017)]. Sertseva nedostatnist ta komorbidni stany. 2017;(1 Suppl 1):1-66. Ukrainian.

Gaasch WH, Zile MR. Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol. 2011;58(17):1733-40. doi: https://doi.org/10.1016/j.jacc.2011.07.022

Goroshi M, Chand D. Myocardial Performance Index (Tei Index): A simple tool to identify cardiac dysfunction in patients with diabetes mellitus. Indian Heart J. 2016;68(1):83-7. doi: https://doi.org/10.1016/j.ihj.2015.06.022

Hoshida S, Hikoso S, Shinoda Y, Tachibana K, Minamisaka T, Shunsuke T, et al. Time-sensitive prognostic performance of an afterload-integrated diastolic index in heart failure with preserved ejection fraction: a prospective multicentre observational study. BMJ Open. 2022;12(8):e059614. doi: https://doi.org/10.1136/bmjopen-2021-059614

Kim ED, Ballew SH, Tanaka H, Heiss G, Coresh J, Matsushita K. Short-Term Prognostic Impact of Arterial Stiffness in Older Adults Without Prevalent Cardiovascular Disease. Hypertension. 2019;74(6):1373-82. doi: https://doi.org/10.1161/HYPERTENSIONAHA.119.13496

Huang WM, Sung SH, Yu WC, Cheng HM, Huang CJ, Guo CY, et al. Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction. PLoS One. 2019;14(8):e0220183. doi: https://doi.org/10.1371/journal.pone.0220183

Hoshida S, Tachibana K, Shinoda Y, Minamisaka T, Seo M, Yano M, et al. Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction. ESC Heart Fail. 2022;9(3):1784-91. doi: https://doi.org/10.1002/ehf2.13865

Taniguchi N, Miyasaka Y, Suwa Y, Harada S, Nakai E, Shiojima I. Heart Failure in Atrial Fibrillation - An Update on Clinical and Echocardiographic Implications. Circ J. 2020;84(8):1212-7. doi: https://doi.org/10.1253/circj.CJ-20-0258

Yang E, Vaishnav J, Song E, Lee J, Schulman S, Calkins H, et al. Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction. ESC Heart Fail. 2022;9(5):2918-27. doi: https://doi.org/10.1002/ehf2.13836

Adhikaree A, Malla R, Sah RK, Maskey A, Rajbhandari S, Sharma D, et al. Echocardiographic assessment of Diastolic Function in patients with Atrial Fibrillation. Nepalese Heart J. 2019;16(2):17-21. doi: https://doi.org/10.3126/njh.v16i2.26312

Oeun B, Hikoso S, Nakatani D, Mizuno H, Suna S, Kitamura T, et al. Prognostic Impact of Echocardiographic Diastolic Dysfunction on Outcomes in Patients With Heart Failure With Preserved Ejection Fraction - Insights From the PURSUIT-HFpEF Registry. Circ J. 2021;86(1):23-33. doi: https://doi.org/10.1253/circj.CJ-21-0300

Pagliaro BR, Mincione G, Taormina A, Ceriotti C, Poggio L, Cannata F, et al. Atrial arrhythmias and heart failure: A "modern view" of an old paradox. Pacing Clin Electrophysiol. 2023;46(5):395-408. doi: https://doi.org/10.1111/pace.14697

Published

2024-02-05

How to Cite

1.
Syvolap VV, Lysenko VA. Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction. Zaporozhye Medical Journal [Internet]. 2024Feb.5 [cited 2024Nov.22];26(1):5-10. Available from: http://zmj.zsmu.edu.ua/article/view/292909